Company: IMCR
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001671927-25-000014
Chunk: 13

Company: Immunocore Holdings plc
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 5
Chunk 13
---
Item 5. Other Information

Resignation of Director

On August 5, 2025, Robert Perez notified the Company’s board of directors of his decision to resign as a member of the board of directors, effective as of September 16, 2025. Mr. Perez’s decision to resign was not the result of any disagreement between Mr. Perez and the Company, the Company’s management, or any other member of the board of directors on any matter relating to the Company’s operations, policies, or practices.

Insider Trading Arrangements

During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities as set forth in the table below. Type of Trading ArrangementName and PositionActionAdoption/ TerminationDateRule 10b5-1(1)Non-Rule 10b5-1(2)Total Ordinary Shares to be Sold(3)Expiration DateDavid BermanEVP, Research and DevelopmentAdoptionMay 9, 2025X471,790November 20, 2026(1)     Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.(2)     “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act. 

(3)     Represents ordinary shares in the form of American Depositary Shares.  

31